These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Are synthetic peptides sensitive enough for screening anti-hepatitis C virus at blood banks? León P; López JA; Elola C; Domingo CJ; Echevarría JM Vox Sang; 1994; 67(1):83-4. PubMed ID: 7526551 [No Abstract] [Full Text] [Related]
14. Hepatitis C following renal transplantation: histopathological correlations. Hestin D; Hussenet F; Hubert J; Renoult E; Frimat L; Jacob C; Le Faou A; Kessler M Transplant Proc; 1995 Aug; 27(4):2468-9. PubMed ID: 7544506 [No Abstract] [Full Text] [Related]
15. Significance of NS3 and NS5 antigens in screening for HCV antibody. Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196 [No Abstract] [Full Text] [Related]
16. Hepatitis C virus antibodies in patients on hemodialysis. San Miguel G; Crespo J; Echevarria S; D'Francisco A; Gomez Ullate P; Pons Romero F Infect Control Hosp Epidemiol; 1992 May; 13(5):254, 256. PubMed ID: 1375612 [No Abstract] [Full Text] [Related]
20. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Chung HT; Lee JS; Lok AS Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]